» Articles » PMID: 32356985

Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1

Overview
Date 2020 May 2
PMID 32356985
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The acetylglucosaminyltransferase-like protein LARGE1 is an enzyme that is responsible for the final steps of the post-translational modifications of dystroglycan (DG), a membrane receptor that links the cytoskeleton with the extracellular matrix in the skeletal muscle and in a variety of other tissues. LARGE1 acts by adding the repeating disaccharide unit [-3Xyl-α1,3GlcAβ1-] to the extracellular portion of the DG complex (α-DG); defects in the gene result in an aberrant glycosylation of α-DG and consequent impairment of its binding to laminin, eventually affecting the connection between the cell and the extracellular environment. In the skeletal muscle, this leads to degeneration of the muscular tissue and muscular dystrophy. So far, a few missense mutations have been identified within the LARGE1 protein and linked to congenital muscular dystrophy, and because no structural information is available on this enzyme, our understanding of the molecular mechanisms underlying these pathologies is still very limited. Here, we generated a 3D model structure of the two catalytic domains of LARGE1, combining different molecular modeling approaches. Furthermore, by using molecular dynamics simulations, we analyzed the effect on the structure and stability of the first catalytic domain of the pathological missense mutation S331F that gives rise to a severe form of muscle-eye-brain disease.

Citing Articles

Metabolic Engineering of Glycofusion Bispecific Antibodies for α-Dystroglycanopathies.

Zhong X, Yan G, Chaturvedi A, Li X, Gao Y, Girgenrath M Antibodies (Basel). 2024; 13(4).

PMID: 39449325 PMC: 11503271. DOI: 10.3390/antib13040083.


Ligand-Induced Conformational and Dynamical Changes in a GT-B Glycosyltransferase: Molecular Dynamics Simulations of Heptosyltransferase I Complexes.

Hassan B, Milicaj J, Ramirez-Mondragon C, Sham Y, Taylor E J Chem Inf Model. 2021; 62(2):324-339.

PMID: 34967618 PMC: 8864558. DOI: 10.1021/acs.jcim.1c00868.


Muscular dystrophy-dystroglycanopathy in a family of Labrador retrievers with a LARGE1 mutation.

Shelton G, Minor K, Guo L, Friedenberg S, Cullen J, Hord J Neuromuscul Disord. 2021; 31(11):1169-1178.

PMID: 34654610 PMC: 8963908. DOI: 10.1016/j.nmd.2021.07.016.


High degree of conservation of the enzymes synthesizing the laminin-binding glycoepitope of α-dystroglycan.

Bigotti M, Brancaccio A Open Biol. 2021; 11(9):210104.

PMID: 34582712 PMC: 8478517. DOI: 10.1098/rsob.210104.


Conserved Conformational Hierarchy across Functionally Divergent Glycosyltransferases of the GT-B Structural Superfamily as Determined from Microsecond Molecular Dynamics.

Ramirez-Mondragon C, Nguyen M, Milicaj J, Hassan B, Tucci F, Muthyala R Int J Mol Sci. 2021; 22(9).

PMID: 33924837 PMC: 8124905. DOI: 10.3390/ijms22094619.

References
1.
Xu J, Zhang Y . How significant is a protein structure similarity with TM-score = 0.5?. Bioinformatics. 2010; 26(7):889-95. PMC: 2913670. DOI: 10.1093/bioinformatics/btq066. View

2.
Clement E, Mercuri E, Godfrey C, Smith J, Robb S, Kinali M . Brain involvement in muscular dystrophies with defective dystroglycan glycosylation. Ann Neurol. 2008; 64(5):573-82. DOI: 10.1002/ana.21482. View

3.
Unligil U, Rini J . Glycosyltransferase structure and mechanism. Curr Opin Struct Biol. 2000; 10(5):510-7. DOI: 10.1016/s0959-440x(00)00124-x. View

4.
Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y . The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2014; 12(1):7-8. PMC: 4428668. DOI: 10.1038/nmeth.3213. View

5.
Briggs D, Yoshida-Moriguchi T, Zheng T, Venzke D, Anderson M, Strazzulli A . Structural basis of laminin binding to the LARGE glycans on dystroglycan. Nat Chem Biol. 2016; 12(10):810-4. PMC: 5030134. DOI: 10.1038/nchembio.2146. View